Analyst Ratings for Rein Therapeutics (RNTX)
RNTX Rating Summary
RNTX Price Target Summary
- Highest: $8.00 (H.C. Wainwright)
- Lowest: $8.00 (H.C. Wainwright)
- Average: $8.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.00 (+769.6%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
Avg. $ Target:
$8.00 (+769.6%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/21/2026 | Brookline Capital Markets | Kemp Dolliver | Downgrade | Hold (Buy) |
N/A (N/A) |
1.20 (0.92) |
-23.33% | Details |
| 9/22/2025 | H.C. Wainwright » Updated 6/1/2026 |
Brandon Folkes | New Coverage | Buy (N/A) |
8.00 (10.00) |
1.21 (0.92) |
-23.97% | Details |
 |
||||||||
|
||||||||
